Laser Efficiency on Metabolic Parameters

Metabolic Syndrome Clinical Trial

Official title:

Effect of Non-invasive on Lipid Metabolism and Renal Out Comes in Metabolic Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06193746
• Other study ID #: P.T.REC/012/004441
• Status: Completed
• Start date: April 10, 2023
• Est. completion date: October 10, 2023

Study information

• Verified date: December 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Non-invasive laser therapy is laser blood irradiation improves many metabolic parameters. So, this study aims to assess the impact of Non-invasive laser therapy on lipid metabolism and renal out comes

Description:

The metabolic syndrome is a constellation of interrelated metabolic risk factors especially central obesity, dyslipidemia, hyperglycemia, which all affect worse their kidney function, and all of this causing mortality. This time line requires a quick procedure that will enable us to implement safe and non-invasive therapeutic instruments adjacent therapy for metabolic syndrome cases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: October 10, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 45 Years to 65 Years

Eligibility

Inclusion Criteria:

• The patients have Metabolic syndrome, started more than one year ago.

• BMI ranged 30- 35Kg/m2.

• They are on medical therapy for more than one year.

• Clinically stable.

Exclusion Criteria:

• taking specific drugs uncontrolled diseases

• cardiovascular instability

• sever e autonomic neuropathy

• infection wound,

• burn, allergy or another external injury

• hypothyroidism

• hemorrhagic disorders

• history of cancer

• pregnant women,

• mental illness as schizophrenia or dementia.

Related Conditions & MeSH terms

• Metabolic Syndrome
• Syndrome

Intervention

Device:
• non-invasive laser therapy
(diode laser, continuous output, in skin contact mode, 0.005W,0.2cm,beam spot area 0.03cm2, 288j/cm ,1800s) in the morning session, we measured lipid profile and kidney function before and after treatment to measure improvement

Locations

Country	Name	City	State
Egypt	Toka	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	lipid profile change	laboratorial measurement of lipid in one mg/dl of blood	12 weeks following end of treatment
Primary	glomerular function range change	laboratorial measurement of glomerular function range in one ml of blood/1minute/1.73m2	12 weeks following end of treatment
Primary	creatinine change	laboratorial measurement of creatinine one mg/DL of blood	12 weeks following end of treatment